Related Experiment Video
Updated: Jul 17, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2
M T Boyd1, N Vlatkovic, D S Haines
1Division of Hematology/Oncology, MCP Hahnemann University Cancer Center, Philadelphia, Pennsylvania 19102, USA. mboyd@liverpool.ac.uk
Abstract:
The MDM2 protein, through its interaction with p53, plays an important role in the regulation of the G(1) checkpoint of the cell cycle. In addition to binding to and inhibiting the transcriptional activation function of the p53 protein, MDM2 binds, inter alia, to RB and the E2F-1.DP-1 complex and in so doing may promote progression of cells into S phase. Mice transgenic for Mdm2 possess cells that have cell cycle regulation defects and develop an altered tumor profile independent of their p53 status. MDM2 also blocks the growth inhibitory effects of transforming growth factor-beta1 in a p53-independent manner. We show here that a novel growth regulatory molecule is also the target of MDM2-mediated inhibition. Using a yeast two-hybrid screen, we have identified a gene that encodes a novel cellular protein (MTBP) that binds to MDM2. MTBP can induce G(1) arrest, which in turn can be blocked by MDM2. Our results suggest the existence of another growth control pathway that may be regulated, at least in part, by MDM2.
Insights
The MDM2 protein regulates cell cycle checkpoints. Researchers discovered a new protein, MTBP, that MDM2 inhibits, suggesting a novel MDM2-regulated growth control pathway.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Biology
Background:
- MDM2 protein is crucial for regulating the G(1) cell cycle checkpoint via its interaction with p53.
- MDM2 also interacts with other proteins like RB and E2F-1.DP-1, potentially promoting cell cycle progression.
- MDM2 influences tumor development and growth inhibition independent of p53 status.
Purpose of the Study:
- To identify novel growth regulatory molecules targeted by MDM2.
- To investigate the role of MDM2 in regulating a newly identified growth control pathway.
Main Methods:
- Yeast two-hybrid screening to identify proteins interacting with MDM2.
- Cell-based assays to assess the impact of MDM2 and the novel protein on cell cycle progression.
Main Results:
- A novel cellular protein, MTBP (MDM2-binding protein), was identified through yeast two-hybrid screening.
- MTBP was found to induce G(1) cell cycle arrest.
- MDM2 was shown to inhibit the G(1) arrest induced by MTBP, demonstrating MDM2-mediated regulation.
Conclusions:
- MDM2 regulates a novel growth control pathway involving MTBP.
- This pathway represents another mechanism by which MDM2 influences cell cycle progression and growth.
- Understanding this MDM2-MTBP interaction may offer new insights into cancer biology and therapeutic strategies.
More Related Videos
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle